Extract Of Ivy is a phytopharmaceutical preparation derived from plant source material through extraction or expression processes that concentrate pharmacologically active secondary metabolites. The chemical fingerprint of Extract Of Ivy varies with botanical species, chemotype, geographic origin, and harvest season, necessitating validated HPLC-based analytical methods capable of identity confirmation and quantification of characteristic marker compounds. PDE derivation for botanical preparations must address the complexity of multiple co-occurring active and potentially toxic constituents, often drawing on the toxicological profile of key individual chemical entities as surrogates for the whole extract.
The OEB assigned to Extract Of Ivy in pharmaceutical manufacturing is determined by structured potency banding based on its pharmacological target, NOAEL from repeat-dose studies, genotoxic classification under ICH M7, and reproductive toxicant status.
